Ashmore Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q3
Sell
-31,838
Closed -$669K 79
2013
Q2
$669K Buy
+31,838
New +$669K 0.1% 43